
Mediclay Pharmaceuticals Private Limited
About Mediclay Pharmaceuticals Private Limited
Data last updated:
Mediclay Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 May 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2022PTC398585.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pramendra Kumar and Shashank Shekhar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 2/928 – G No. – 14 – C Sonia Vihar, Delhi, India – 110094.
As per the financials filed for FY 2024, the company reported a revenue of ₹67,123, a growth of 126% compared to the previous year. For the same year it recorded a net profit of ₹9,414 (net margin 14%) and EBITDA of ₹12,724 (EBITDA margin 19%).
Company details
Contact details
Mediclay Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressE – 2/928 – G No. – 14 – C Sonia Vihar, Delhi, India – 110094
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mediclay Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Mediclay Pharmaceuticals Private Limited, buy the company report.
Financials of Mediclay Pharmaceuticals Private Limited
FY 2025 filings availableMediclay Pharmaceuticals Private Limited reported revenue of ₹67,123 (up 126% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 126% in the latest year. EBITDA rose 576% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹12,724 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹9,414 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 19% | |
| Net Profit Margin | 14% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Mediclay Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mediclay Pharmaceuticals Private Limited
Mediclay Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramendra Kumar | Director | 19 May 2022 | 4 Years 5 Months | Current |
| Shashank Shekhar | Additional Director | 12 Jan 2025 | 1 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Mediclay Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediclay Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mediclay Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mediclay Pharmaceuticals Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Chandani Kumari ceased to be Director on 12 Jan 2025.
Frequently asked questions
Mediclay Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 May 2022 (4+ years old) and is registered under CIN U24100DL2022PTC398585.
Mediclay Pharmaceuticals has 2 current directors:
- Pramendra Kumar - Director
- Shashank Shekhar - Additional Director
The latest financial statements of Mediclay Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Mediclay Pharmaceuticals is U24100DL2022PTC398585. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediclay Pharmaceuticals was incorporated on 19 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Chandani Kumari ceased to be Director on 12 Jan 2025. Shashank Shekhar was appointed as Additional Director on 12 Jan 2025. Chandani Kumari was appointed as Director on 19 May 2022. Mediclay Pharmaceuticals has 4 board changes on record in total.
The registered office of Mediclay Pharmaceuticals is at E – 2928 – G No. – 14 – C Sonia Vihar, Delhi, India – 110094.
Mediclay Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Mediclay Pharmaceuticals can be reached at its registered office: E – 2928 – G No. – 14 – C Sonia Vihar, Delhi, India – 110094.
Mediclay Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

